Related Experiment Video

Updated: Mar 16, 2026

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

7.4K

Outcomes Analysis and Quality Improvement in Children With Congenital and Acquired Cardiovascular Disease

Howard E Jeffries1, Michael G Gaies

  • 11Department of Pediatrics, Section of Critical Care Medicine, University of Washington School of Medicine, Seattle Children's Hospital, Seattle, WA. 2Department of Pediatrics, Section of Cardiology, University of Michigan Medical School, C.S. Mott Children's Hospital, Ann Arbor, MI.

Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
|August 5, 2016
PubMed

Insights

This review discusses quality improvement and outcomes analysis for pediatric cardiovascular disease. It highlights challenges in measuring quality and outcomes in pediatric cardiac critical care, while noting emerging solutions.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Health Outcomes Research

Background:

  • Outcomes analysis and quality improvement are crucial in pediatric cardiovascular disease care.
  • Challenges exist in measuring quality and outcomes in pediatric cardiac critical care due to patient diversity and complex care contributions.
  • Existing risk-adjustment methods are inadequate for this specific patient population.

Purpose of the Study:

  • To review the current state of outcomes analysis and quality improvement in pediatric acquired and congenital cardiovascular disease.
  • To emphasize the definition and measurement of outcomes and quality in pediatric cardiac critical care.
  • To discuss risk stratification systems in this field.

Main Methods:

  • Literature review utilizing MEDLINE and PubMed databases.
  • Analysis of current practices in pediatric cardiac critical care.
  • Examination of challenges and emerging solutions in quality improvement.

Main Results:

  • Measuring quality and outcomes in pediatric cardiac critical care is complex.
  • Diverse patient populations and difficulty attributing ICU team contributions pose significant barriers.
  • Inadequate risk-adjustment methods hinder accurate outcome assessment.

Conclusions:

  • Despite challenges, new solutions are emerging for quality improvement in pediatric cardiac critical care.
  • Lessons from other quality improvement initiatives offer a foundation for progress.
  • Continued development of risk-adjustment and outcome measurement is essential.
Abstract

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

12.4K
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

1.5K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
618
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
716
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.8K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
353